Zhixiang Zhang

Years Active: 2018-2024
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Ruifeng Wang, Shuhua Ma, Nengwei Xu, Yumiao Gan, Pengya Li, Jingying Zhang, Zhixiang Zhang, Qingyang Gu, Jian Xiang
Developing a Novel Enzalutamide-Resistant Prostate Cancer Model via AR F877L Mutation in LNCaP Cells. Current protocols 4 (4) (2024)
Ruifeng Wang, Shuhua Ma, Nengwei Xu, Yumiao Gan, Pengya Li, Jingying Zhang, Zhixiang Zhang, Qingyang Gu, Jian Xiang
Developing a Novel Enzalutamide-Resistant Prostate Cancer Model via AR F877L Mutation in LNCaP Cells. Current protocols 4 (4) (2024)
Thijs J Hagenbeek, Joshua D Webster, Noelyn M Kljavin, Matthew T Chang, Trang Pham, Ho-June Lee, Christiaan Kljin, Allen G Cai, Klara Totpal, Buvana Ravishankar, Naiying Yang, Da-Hye Lee, Kevin B Walsh, Georgia Hatzivassiliou, Cecile C de la Cruz, Stephen E Gould, Xiumin Wu, Wyne P Lee, Shuqun Yang, Zhixiang Zhang, Qingyang Gu, Qunsheng Ji, Erica L Jackson, Dae-Sik Lim, Anwesha Dey
The Hippo pathway effector TAZ induces TEAD-dependent liver inflammation and tumors. Science signaling 11 (547) (2018)

Zhixiang Zhang.css-eqlu8i{font-size:small;padding-left:4px;}